Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |